ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,225Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1107

$1.55M Total Retail Price of All Prescriptions

Rank: 19 out of 1107

838 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 838 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

36% of this provider’s 838 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 19,627 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 2,134 1,007 S3 1 1
LISINOPRIL 1,274 718 2 2
LEVOTHYROXINE SODIUM 1,202 849 3 3
PRAVASTATIN SODIUM 841 544 4 12
AMLODIPINE BESYLATE 822 620 5 6
METFORMIN HCL 751 418 6 8
GABAPENTIN 704 297 7 9
METOPROLOL TARTRATE 648 429 8 10
FUROSEMIDE 634 443 9 7
SIMVASTATIN 627 439 10 5
OMEPRAZOLE 608 324 11 4
RANITIDINE HCL 576 349 12 21
AZITHROMYCIN 468 297 13 35
TRAMADOL HCL 439 221 14 26
CLONIDINE HCL 433 273 15 53
ATORVASTATIN CALCIUM 421 279 16 13
METOPROLOL SUCCINATE 416 281 17 16
CLOPIDOGREL 416 230 17 28
HYDROCHLOROTHIAZIDE 392 312 19 11
NEXIUM 365 211 20 18
ATENOLOL 362 247 21 19
POTASSIUM CHLORIDE 348 225 22 14
PLAVIX 341 206 23 39
ISOSORBIDE MONONITRATE ER 335 257 24 34
PANTOPRAZOLE SODIUM 302 179 25 30
CITALOPRAM HBR 263 134 26 17
WARFARIN SODIUM 257 165 27 15
KETOPROFEN 255 121 10 28 301
AMITRIPTYLINE HCL 249 139 R 29 48
CARVEDILOL 246 150 30 27
ZOLPIDEM TARTRATE 234 154 31 22
DILTIAZEM 24HR CD 210 130 32 126
CRESTOR 210 129 32 23
GLIPIZIDE ER 209 145 34 115
TRAZODONE HCL 203 77 35 33
LOSARTAN POTASSIUM 198 184 36 29
TAMSULOSIN HCL 189 124 37 30
SPIRONOLACTONE 185 147 38 72
DOXAZOSIN MESYLATE 184 125 39 92
SPIRIVA 178 118 40 57
ENDOCET 175 102 S2 41 91
POLYETHYLENE GLYCOL 3350 170 135 42 46
ALENDRONATE SODIUM 169 116 43 41
AMOXICILLIN 169 105 43 90
PREMARIN 165 87 R 45 149
FLUOXETINE HCL 164 89 46 47
ALPRAZOLAM 161 110 47 87
MELOXICAM 158 76 48 25
SERTRALINE HCL 156 86 49 20
LOVAZA 155 72 50 101
ALLOPURINOL 155 124 50 36
PROAIR HFA 148 50 52 37
AMLODIPINE BESYLATE-BENAZEPRIL 145 93 53 77
GLIPIZIDE XL 145 97 53 166
GLIPIZIDE 143 92 55 64
PROMETHAZINE HCL 140 42 R 56 44
INSULIN SYRINGE 137 81 57 78
GLYBURIDE 136 97 R 58 68
TIZANIDINE HCL 135 49 59 73
KLOR-CON M20 134 114 60 75
CEPHALEXIN 134 78 60 81
QUINAPRIL HCL 133 83 62 145
LANSOPRAZOLE 132 63 63 102
TRICOR 131 66 64 95
ADVAIR DISKUS 130 80 65 54
ESCITALOPRAM OXALATE 129 53 66 82
TRIAMCINOLONE ACETONIDE 128 77 67 137
LANTUS 128 97 67 49
GLYBURIDE-METFORMIN HCL 127 93 R 69 165
HYDROXYZINE HCL 123 65 R 70 162
GEMFIBROZIL 120 62 71 107
RAMIPRIL 119 76 72 84
HYDRALAZINE HCL 117 102 73 99
PAROXETINE HCL 116 45 74 45
DIOVAN 116 94 74 51
CYMBALTA 115 25 76 50
METFORMIN HCL ER 114 97 77 58
IBUPROFEN 110 34 78 63
ROPINIROLE HCL 110 51 78 69
JANUVIA 109 77 80 60
DILTIAZEM ER 106 79 81 139
PREDNISONE 101 71 82 40
ENALAPRIL MALEATE 100 94 83 98
METHADONE HCL 98 62 S2 84 201
FLUCONAZOLE 96 41 85 150
COMBIVENT 94 57 86 112
CIPROFLOXACIN HCL 94 67 86 59
SINGULAIR 92 42 88 65
VENTOLIN HFA 90 65 89 97
CYCLOBENZAPRINE HCL 88 20 R 90 56
LIPITOR 87 41 91 109
LUNESTA 83 41 92 329
DOXYCYCLINE HYCLATE 82 52 93 128
DILTIAZEM 24HR ER 80 80 94 172
NITROSTAT 77 57 95 188
LOVASTATIN 75 53 96 55
RANEXA 74 35 97 272
KLOR-CON M10 72 44 98 159
LEVEMIR 72 37 98 191
LEVOFLOXACIN 70 49 100 71
BUSPIRONE HCL 67 58 101 107
TRIAMTERENE-HCTZ 67 51 101 62
DONEPEZIL HCL 66 66 103 32
DIGOXIN 66 38 103 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 46 103 24
BUPROPION HCL SR 65 19 106 190
LOSARTAN-HYDROCHLOROTHIAZIDE 65 61 106 66
FEXOFENADINE HCL 64 32 108 260
VENLAFAXINE HCL ER 61 35 109 117
SYNTHROID 60 50 110 70
LYRICA 59 28 111 83
TOPIRAMATE 58 16 112 160
METOCLOPRAMIDE HCL 57 37 113 116
CARISOPRODOL 57 36 R 113 146
ESTRADIOL 54 31 R 115 151
ACTOS 54 43 115 132
AVODART 53 38 117 204
CILOSTAZOL 53 36 117 194
NASONEX 52 25 119 206
DIOVAN HCT 52 18 119 106
NAPROXEN 52 36 119 80
MONTELUKAST SODIUM 52 24 119 118
GLIMEPIRIDE 51 50 123 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.